| Bioactive compounds isolated from marine bacteria |
| Bacillus licheniformis |
α-D-galactopyranosyl-(1→2)-glycerol-phosphate |
Antibiofilm |
Escherichia coli and Pseudomonas fluorescens
|
Clinical |
|
Alteromonas sp. |
Ubiquinone-8 |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
Environmental |
|
Acinetobacter sp. |
6-bromoindole-3-carboxaldehyde |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
Environmental |
|
Pseudomonas sp. |
Pyolipic acid |
Antifouling |
Larval settlement under laboratory and field experiment assays |
Environmental |
|
Pseudomonas sp. |
Phenazine-1-carboxylic acid |
Antifouling |
Larval settlement under laboratory and field experiment assays |
Environmental |
|
Pseudomonas sp. |
2-alkylquinol-4-ones |
Antifouling |
Larval settlement under laboratory and field experiment assays |
Environmental |
| Streptomyces praecox |
Diketopiperazines |
Antifouling |
Larval settlement under laboratory and field experiment assays |
Environmental |
| Streptomyces violaceoruber |
3-octa-1′,3′-dienyl-4-methylfuran-2(5H)-one |
Antifouling |
Zoospores of Ulva pertusa, the diatom Navicula annexa, and the mussel Mytilus edulis
|
Environmental |
| Streptomyces violaceoruber |
3-octa-1′-enyl-4-methylfuran-2(5H)-one |
Antifouling |
Zoospores of Ulva pertusa, the diatom Navicula annexa, and the mussel Mytilus edulis
|
Environmental |
|
Vibrio sp. QY101
|
Exopolysaccharide A101 |
Antibiofilm |
Pseudomonas aeruginosa FRD1 |
Clinical |
| Bioactive compounds isolated from marine fungi |
| Letendraea helminthicola |
3-methyl-N-(2-phenylethyl) butanamide |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
Industrial/Environmental |
|
Scopulariopsis sp. |
Dihydroquinolin-2(1H)-one |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
Industrial/Environmental |
| Letendraea helminthicola |
Cyclo (D-Pro-D-Phe) |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
|
| Cochliobolus lunatus |
Resorcyclic acid lactones |
Antifouling |
Larval settlement of barnacle Balanus amphitrite
|
Industrial/Environmental |
| Emericella variecolor |
Ophiobolin K |
Antibiofilm |
Mycobacterium bovis |
Clinical |
| Emericella variecolor |
6-epi-ophiobolin K |
Antibiofilm |
Mycobacterium smegmatis |
Clinical |
| Emericella variecolor |
6-epi-ophiobolin |
Antibiofilm |
Mycobacterium smegmatis |
Clinical |
| Unidentified marine fungus |
Mevalonolactone |
Antibiofilm |
Staphylococcus epidermidis |
Clinical |
| Marine Penicillium sp. |
Cyclo(L-Tyr-L-Leu) |
Antibiofilm |
Staphylococcus epidermidis |
Clinical/Environmental |
| Penicillium commune |
Cyclo(L-Leu-L-Pro) |
Antibiofilm |
Staphylococcus aureus |
Clinical/Environmental |
|
Cladosporium sp. |
F14 cyclo-(Phe-Pro) |
Antibiofilm |
Loktanella hongkongenis, Micrococcus luteus and Ruegeria sp. |
Clinical/Environmental |
|
Cladosporium sp. |
cyclo-(Val-Pro) 4 |
Antibiofilm |
Loktanella hongkongenis |
Clinical/Environmental |
| Aspergillus flavipes |
Flavipesin A 49 |
Antibiofilm |
Staphylococcus aureus and Bacillus subtilis
|
Clinical |
| Bioactive compounds isolated from marine algae |
| Chondrus crispus |
(+)—Usnic acid |
Antibiofilm |
Cobetia marina and Marinobacter hydrocarbonoclasticus
|
Environmental |
| Chondrus crispus |
Juglone |
Antibiofilm |
Cobetia marina and Marinobacter hydrocarbonoclasticus
|
Environmental |
| Laurencia elata |
Elatol |
Antifouling |
Leishmania amazonensis |
Clinical |
| Halidrys siliquosa |
Organic extract |
Antibiofilm |
Staphylococcus; Streptococcus; Enterococcus; Pseudomonas; Stenotrophomonas; and Chromobacterium
|
Clinical |